US equities
|
MU
$928.76
▲+0.00%
SNDK
$1,304.84
▲+0.00%
SKHY
$145.36
▲+0.00%
TSLA
$407.46
▲+0.00%
NVDA
$217.94
▲+0.00%
GOOGL
$320.58
▲+0.00%
SPCX
$148.58
▲+0.00%
INTC
$93.74
▲+0.00%
MU
$928.76
▲+0.00%
SNDK
$1,304.84
▲+0.00%
SKHY
$145.36
▲+0.00%
TSLA
$407.46
▲+0.00%
NVDA
$217.94
▲+0.00%
GOOGL
$320.58
▲+0.00%
SPCX
$148.58
▲+0.00%
INTC
$93.74
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about XE:GXI
Recent news which mentions XE:GXI
The weight-loss drugs are coming for these companies — but here’s why Coke, others, may be spared, says JPMorgan
October 24, 2023
Tickers
A
AAPL
AMC
AVTR
Tags
MSFT
AMC
BX:TMUBMUSD02Y
From
MarketWatch
As Ozempic/Wegovy frenzy continues, Morgan Stanley lifts forecasts for weight-loss drugs to $77 billion
July 21, 2023
Tickers
ALT
CTLT
GPCR
LLY
Tags
XE:GXI
CH:NOVN
ALT
From
MarketWatch